A lot of the value I see at Artivion ( AORT ) still lives in the clinic and is dependent upon clinical results, FDA approvals, and successful commercialization, but the company does continue to execute well, building confidence in the longer-term execution story.Analyst’s Disclosure:I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I ...